RxDoctor Payments Data

Mallory Meyer, APRN

Psychiatric/Mental Health · Mankato, MNNPI 1578183604

Payments from drug & device makers

$228in general payments, 2019–2025

Across 15 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$30
  • Tempus AI, Inc$29
  • Corium, LLC$29
  • Alkermes, Inc.$28
  • Indivior Inc.$18
  • E.r. Squibb & Sons, L.L.C.$16
  • plus $78 from 6 others

What the payments were for

  • Food & beverage$21594%
  • Education$146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$228 in reported general payments places this provider in the 80th percentile of 407 psychiatric/mental health providers in Minnesota.

See all psychiatric/mental health providers in Minnesota

Medicare billing

Part B allowed, 2024
$48,662
Medicare patients
70
Services billed
546

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate11$93,202
Austedo XrDeutetrabenazine11$80,535
Invega SustennaPaliperidone Palmitate23$73,605
AristadaAripiprazole Lauroxil15$56,884
VraylarCariprazine Hcl37$54,434
LybalviOlanzapine/Samidorphan Malate25$40,823
RexultiBrexpiprazole27$39,927
FanaptIloperidone14$22,363
Aripiprazole149$16,838
AuvelityDextromethorphan Hbr/Bupropion13$13,092
BelsomraSuvorexant20$9,977
Quetiapine Fumarate263$8,623
TrintellixVortioxetine Hydrobromide14$6,807
Clozapine106$4,754
Lamotrigine292$4,016

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada, Lybalvi$28$97,70640 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$12$80,53511 claims
AbbVieVraylar$30$54,43437 claims
Otsuka America Pharmaceutical, Inc.Rexulti$14$39,92727 claims
Almatica Pharma LLCSertraline Hcl$14$1,942155 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 407 psychiatric/mental health providers in Minnesota.

Other psychiatric/mental health in Mankato

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →